Skip to main content

PDAC

1
Pipeline Programs
4
Companies
3
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Anocca
AnoccaSweden - Södertälje
1 program
1
ANOC-001Phase 1/21 trial
Active Trials
NCT07145450Recruiting96Est. Jul 2030
UNION therapeutics
UNION therapeuticsDenmark - Hellerup
1 program
68Ga-FAPI Positron Emission Tomography-Computed TomographyN/A1 trial
Active Trials
NCT05275985Unknown80Est. Jun 2023
Tango Therapeutics
Tango TherapeuticsMA - Cambridge
1 program
TNG462PHASE_1_2
REVOLUTION Medicines
REVOLUTION MedicinesREDWOOD CITY, CA
1 program
TNG462PHASE_1_21 trial
Active Trials
NCT06922591Recruiting183Est. Dec 2027

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
2027
2028
2029
2030
AnoccaANOC-001
REVOLUTION MedicinesTNG462
UNION therapeutics68Ga-FAPI Positron Emission Tomography-Computed Tomography

Clinical Trials (3)

Total enrollment: 359 patients across 3 trials

NCT07145450AnoccaANOC-001

Master Protocol of TCR-modified T Cell Therapy Targeting HLA-restricted KRAS Antigen Administered in Adult Patients With Metastatic or Locally Advanced PDAC

Start: Jul 2025Est. completion: Jul 203096 patients
Phase 1/2Recruiting
NCT06922591REVOLUTION MedicinesTNG462

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

Start: May 2025Est. completion: Dec 2027183 patients
Phase 1/2Recruiting
NCT05275985UNION therapeutics68Ga-FAPI Positron Emission Tomography-Computed Tomography

68Ga-FAPI PET/CT in Pancreatic Ductal Carcinoma

Start: Mar 2022Est. completion: Jun 202380 patients
N/AUnknown

Related Jobs

Executive Director, US PDAC Marketing

REVOLUTION MedicinesREVOLUTION Medicines
Remote
1w ago
$252K - $315K/yr

Vice President, Marketing, PDAC

REVOLUTION MedicinesREVOLUTION Medicines
Remote
2w ago
$294K - $367K/yr

Senior Manager Marketing, PDAC

REVOLUTION MedicinesREVOLUTION Medicines
Remote
3w ago
$150K - $189K/yr

Director, Marketing, PDAC

REVOLUTION MedicinesREVOLUTION Medicines
Remote
4w ago
$201K - $251K/yr

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 actively recruiting trials targeting 359 patients
4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.